Screening the Single Euploid Embryo : Molecular Genetics in Reproductive Medicine

Intended for readers with a background in fertility medicine as well as those less familiar with IVF, this comprehensive work presents an update on preimplantation genetic testing to enable single embryo transfer (SET). An international cast of contributors explains the treatment sequence―from ovulation induction to luteal support―aiming to transfer only one euploid embryo. Applications of molecular techniques for gamete and embryo assessment are fully detailed, with a focus on the strengths and limitations of each. In addition, expert commentary is shared across a range of regulatory challenges associated with embryo screening and cryopreservation. As access to advanced reproductive technology increases against a sharper background of healthcare reform, clinicians, economists, bioethicists and legislators alike will find this new volume relevant and highly accessible.

Eric Scott Sills received his undergraduate degree from Vanderbilt and holds a PhD (molecular biology) from London’s University of Westminster. Dr. Sills was awarded the MD degree from University of Tennessee in 1992. After a gynecology residency at NYU Downtown Hospital, he completed his sub-specialty training in reproductive endocrinology at Cornell University. Having authored more than 100 peer-reviewed publications, Dr. Sills served as editor-in-chief for the Journal of Experimental & Clinical Assisted Reproduction from 2004–2014. He is board-certified by the American Board of Obstetrics and Gynecology, and is a Fellow of the American College of Obstetricians and Gynecologists, American College of Surgeons, Royal College of Physicians (Ireland), and Society of Biology (UK). At present, Dr. Sills is Medical Director at the Center for Advanced Genetics, an in vitro fertilization program based in Carlsbad, California. He is registered and/or licensed for medicine in California, New York and the United Kingdom.